Dietary regulation of P-gp function and expression

Expert Opinion on Drug Metabolism and Toxicology

Volumn 5, Issue 7, 2009, Pages 789-801

  Zhang, Wenxia ^a   Han, Yi ^b   Siok, Lam Lim ^c   Lee, Yong Lim ^d  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Food drug interactions; Fruit juice; Herb; P gp regulation; Spice; Tea; Vegetable

Indexed keywords

CAPSAICIN; CELIPROLOL; CURCUMIN; CYCLOSPORIN; DAUNORUBICIN; DEXTROMETHORPHAN; DIGOXIN; ETHINYLESTRADIOL; FEXOFENADINE; GINSENOSIDE; GLYCOPROTEIN P; GREEN TEA EXTRACT; HYPERICUM PERFORATUM EXTRACT; INDINAVIR; NORETHISTERONE; PHENYTOIN; PIPERINE; PROTOPANAXATRIOL; RIFAMPICIN; RITONAVIR; SAQUINAVIR; SILIBININ; SILYBUM MARIANUM EXTRACT; SILYMARIN; SIMVASTATIN; TACROLIMUS; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL; VINBLASTINE; VINCRISTINE;

AREA UNDER THE CURVE; BLACK PEPPER; CELL FUNCTION; DIETARY INTAKE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INHIBITION; DRUG METABOLISM; DRUG POTENTIATION; DRUG TRANSPORT; DRUG UPTAKE; FOOD DRUG INTERACTION; FRUIT JUICE; GARLIC; GASTROINTESTINAL TOXICITY; GINGER; GINSENG; GRAPEFRUIT JUICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERICUM PERFORATUM; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; ORANGE JUICE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PUMMELO; PUMMELO JUICE; REVIEW; SILYBUM MARIANUM; TEA; VACCARIA; VEGETABLE;

ANIMALS; DIET; FOOD-DRUG INTERACTIONS; GENE EXPRESSION REGULATION; HERB-DRUG INTERACTIONS; HUMANS; P-GLYCOPROTEIN;

EID: 67650726932     PISSN: 17425255     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425250902997967     Document Type: Review

References (163)

1. Ueda K, Cardarelli C, Gottesman MM, Pastan I. Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 1987;84(9):3004-3008
2. Mattern J, Koomagi R, Volm M. Expression of drug resistance gene products during progression of lung carcinomas. Oncol Rep 2002;9(6):1181-1184
3. Hinoshita E, Uchiumi T, Taguchi K, et al. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas. Clin Cancer Res 2000;6(6):2401-2407 (Pubitemid 30399208)
4. Penson RT, Oliva E, Skates SJ, et al. Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples. Gynecol Oncol 2004;93(1):98-106 (Pubitemid 38429555)
5. Thiebaut F, Tsuruo T, Hamada H, et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 1987;84(21):7735-7738
6. Marzolini C, Paus E, Buclin T, Kim RB. Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin Pharmacol Ther 2004;75(1):13-33 (Pubitemid 38130115)
7. Chan LM, Lowes S, Hirst BH. The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur J Pharm Sci 2004;21(1):25-51 (Pubitemid 38050202)
8. Cordon-Cardo C, O'Brien JP, Casals D, et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 1989;86(2):695-698 (Pubitemid 19037807)
9. Sugawara I, Kataoka I, Morishita Y, et al. Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res 1988;48(7):1926-1929 (Pubitemid 18100174)
10. McGown AT, Murphy D, Swindell R, et al. Correlation of drug resistance-associated parameters in ovarian tumor biopsies. Int J Gynecol Cancer 1994;4(4):241-249
11. Dey S, Ramachandra M, Pastan I, et al. Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein. Proc Natl Acad Sci USA 1997;94(20):10594-10599 (Pubitemid 27430779)
12. Shapiro AB, Ling V. Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein. Eur J Biochem 1997;250(1):122-129 (Pubitemid 27504591)
13. Pascaud C, Garrigos M, Orlowski S. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents. Biochem J 1998;333( Pt 2):351-358 (Pubitemid 28379536)
14. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993;62:385-427 (Pubitemid 23237876)
15. Igel S, Drescher S, Murdter T, et al. Increased absorption of digoxin from the human jejunum due to inhibition of intestinal transporter-mediated efflux. Clin Pharmacokinet 2007;46(9):777-785 (Pubitemid 47347449)
16. Green H, Soderkvist P, Rosenberg P, et al. ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel. J Pharm Sci 2008;97(6):2045-2048
17. Fenner KS, Troutman MD, Kempshall S, et al. Drug-drug interactions mediated through P-glycoprotein: clinical relevance and in vitro-in vivo correlation using digoxin as a probe drug. Clin Pharmacol Ther 2009;85(2):173-181
18. Grenier J, Fradette C, Morelli G, et al. Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. Clin Pharmacol Ther 2006;79(3):255-262 (Pubitemid 43297017)
19. Schinkel AH, Wagenaar E, van Deemter L, et al. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 1995;96(4):1698-1705
20. Kane GC, Lipsky JJ. Drug-grapefruit juice interactions. Mayo Clin Proc 2000;75(9):933-942
21. Bailey DG, Dresser GK, Kreeft JH, et al. Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients. Clin Pharmacol Ther 2000;68(5):468-477 (Pubitemid 30953866)
22. Tsukamoto S, Tomise K, Miyakawa K, et al. CYP3A4 inhibitory activity of new bisalkaloids, dipiperamides D and E, and cognates from white pepper. Bioorg Med Chem 2002;10(9):2981-2985 (Pubitemid 34761877)
23. Barthomeuf C, Grassi J, Demeule M, et al. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin. Cancer Chemother Pharmacol 2005;56(2):173-181 (Pubitemid 40884272)
24. Xu H, Williams KM, Liauw WS, et al. Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide. Br J Pharmacol 2008;153(7):1579-1586
25. Anderson GD, Rosito G, Mohustsy MA, Elmer GW. Drug interaction potential of soy extract and Panax ginseng. J Clin Pharmacol 2003;43(6):643-648 (Pubitemid 36613123)
26. Leclercq I, Desager JP, Horsmans Y. Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress. Clin Pharmacol Ther 1998;64(2):144-149 (Pubitemid 28423849)
27. Suganuma M, Kurusu M, Suzuki K, et al. Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of GADD153 gene. Int J Cancer 2006;119(1):33-40
28. Takanaga H, Ohnishi A, Matsuo H, Sawada Y. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in Caco-2 cells. Biol Pharm Bull 1998;21(10):1062-1066 (Pubitemid 28513983)
29. Ikegawa T, Ushigome F, Koyabu N, et al. Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells. Cancer Lett 2000;160(1):21-28
30. Honda Y, Ushigome F, Koyabu N, et al. Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux. Br J Pharmacol 2004;143(7):856-864 (Pubitemid 39664844)
31. Tian R, Koyabu N, Takanaga H, et al. Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates. Pharm Res 2002;19(6):802-809 (Pubitemid 34686739)
32. Di Marco MP, Edwards DJ, Wainer IW, Ducharme MP. The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein. Life Sci 2002;71(10):1149-1160 (Pubitemid 34722546)
33. Egashira K, Fukuda E, Onga T, et al. Pomelo-induced increase in the blood level of tacrolimus in a renal transplant patient. Transplantation 2003;75(7):1057 (Pubitemid 36438541)
34. Xu J, Go ML, Lim LY. Modulation of digoxin transport across Caco-2 cell monolayers by citrus fruit juices: lime, lemon, grapefruit, and pummelo. Pharm Res 2003;20(2):169-176 (Pubitemid 36269723)
35. Lim SL, Lim LY. Effects of citrus fruit juices on cytotoxicity and drug transport pathways of Caco-2 cell monolayers. Int J Pharm 2006;307(1):42-50 (Pubitemid 41773250)
36. Lim SL, Tan MC, Lim LY. Effects of citrus fruit juices on P-glycoprotein-mediated transport in L-MDR1 cells and CYP3A4-mediated metabolism in human intestinal microsomes. Tree Forestry Sci Biotech 2008;2(Special Issue 1):102-111
37. Egashira K, Ohtani H, Itoh S, et al. Inhibitory effects of pomelo on the metabolism of tacrolimus and the activities of CYP3A4 and P-glycoprotein. Drug Metab Dispos 2004;32(8):828-833 (Pubitemid 38955612)
38. Guo LQ, Fukuda K, Ohta T, Yamazoe Y. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. Drug Metab Dispos 2000;28(7):766-771 (Pubitemid 30470826)
39. de Castro WV, Mertens-Talcott S, Derendorf H, Butterweck V. Grapefruit juice-drug interactions: grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells. J Pharm Sci 2007;96(10):2808-2817 (Pubitemid 47597829)
40. de Castro WV, Mertens-Talcott S, Derendorf H, Butterweck V. Effect of grapefruit juice, naringin, naringenin, and bergamottin on the intestinal carrier-mediated transport of talinolol in rats. J Agric Food Chem 2008;56(12):4840-4845 (Pubitemid 351999419)
41. Albach RF, Redman GH. Composition and inheritance of flavanones in citrus fruit. Phytochemistry 1969;8:127-143
42. Barret HC, Rhodes AM. A numerical taxonomic study of affinity relationship in cultivated citrus and its close relatives. Syst Bot 1976;1:105-136
43. Rashid J, McKinstry C, Renwick AG, et al. Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice. Br J Clin Pharmacol 1993;36(5):460-463 (Pubitemid 23344157)
44. Romiti N, Tramonti G, Donati A, Chieli E. Effects of grapefruit juice on the multidrug transporter P-glycoprotein in the human proximal tubular cell line HK-2. Life Sci 2004;76(3):293-302 (Pubitemid 39452911)
45. Schwarz UI, Seemann D, Oertel R, et al. Grapefruit juice ingestion significantly reduces talinolol bioavailability. Clin Pharmacol Ther 2005;77(4):291-301 (Pubitemid 40470385)
46. Kioka N, Hosokawa N, Komano T, et al. Quercetin, a bioflavonoid, inhibits the increase of human multidrug resistance gene (MDR1) expression caused by arsenite. FEBS Lett 1992;301(3):307-309
47. Grenier J, Fradette C, Morelli G, et al. Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. Clin Pharmacol Ther 2006;79(3):255-262 (Pubitemid 43297017)
48. Choi BH, Kim CG, Lim Y, et al. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/ NF kappa B pathway. Cancer Lett 2008;259(1):111-118 (Pubitemid 350235095)
49. Anuchapreeda S, Leechanachai P, Smith MM, et al. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol 2002;64(4):573-582 (Pubitemid 34886455)
50. Romiti N, Tongiani R, Cervelli F, Chieli E. Effects of curcumin on P-glycoprotein in primary cultures of rat hepatocytes. Life Sci 1998;62(25):2349-2358 (Pubitemid 28273164)
51. Hou XL, Takahashi K, Tanaka K, et al. Curcuma drugs and curcumin regulate the expression and function of P-gp in Caco-2 cells in completely opposite ways. Int J Pharm 2008;358(1-2):224-229
52. Zhang W, Lim LY. Effects of spice constituents on P-glycoprotein-mediated transport and CYP3A4-mediated metabolism in vitro. Drug Metab Dispos 2008;36(7):1283-1290 (Pubitemid 351929312)
53. Zhang W, Tan TM, Lim LY. Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats. Drug Metab Dispos 2007;35(1):110-115 (Pubitemid 46036483)
54. Marczylo TH, Verschoyle RD, Cooke DN, et al. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol 2007;60(2):171-177 (Pubitemid 46742531)
55. Limtrakul P, Chearwae W, Shukla S, et al. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Mol Cell Biochem 2007;296(1-2):85-95
56. Nabekura T, Kamiyama S, Kitagawa S. Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. Biochem Biophys Res Commun 2005;327(3):866-870 (Pubitemid 40092828)
57. Han Y, Tan TMC, Lim LY. Effects of capsaicin on P-gp function and expression in Caco-2 cells. Biochem Pharmacol 2006;71(12):1727-1734 (Pubitemid 43732499)
58. Zutshi RK, Singh R, Zutshi U, et al. Influence of piperine on rifampicin blood levels in patients of pulmonary tuberculosis. J Assoc Physicians India 1985;33(3):223-224
59. Bano G, Amla V, Raina RK, et al. The effect of piperine on pharmacokinetics of phenytoin in healthy volunteers. Planta Med 1987;53(6):568-569 (Pubitemid 18004300)
60. Velpandian T, Jasuja R, Bhardwaj RK, et al. Piperine in food: interference in the pharmacokinetics of phenytoin. Eur J Drug Metab Pharmacokinet 2001;26(4):241-247 (Pubitemid 34076170)
61. Koul S, Koul JL, Taneja SC, et al. Structure-activity relationship of piperine and its synthetic analogues for their inhibitory potentials of rat hepatic microsomal constitutive and inducible cytochrome P450 activities. Bioorg Med Chem 2000;8(1):251-268 (Pubitemid 30125675)
62. Suresh D, Srinivasan K. Influence of curcumin, capsaicin, and piperine on the rat liver drug-metabolizing enzyme system in vivo and in vitro. Can J Physiol Pharmacol 2006;84(12):1259-1265 (Pubitemid 46707374)
63. Volak LP, Ghirmai S, Cashman JR, Court MH. Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor. Drug Metab Dispos 2008;36(8):1594-1605
64. Bhardwaj RK, Glaeser H, Becquemont L, et al. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 2002;302(2):645-650 (Pubitemid 34787231)
65. Han Y, Chin TAN, Tm LIM. In vitro and in vivo evaluation of the effects of piperine on P-gp function and expression. Toxicol Appl Pharmacol 2008;230(3):283-289
66. Durr D, Stieger B, Kullak-Ublick GA, et al. St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther 2000;68(6):598-604 (Pubitemid 32059985)
67. Hellum BH, Nilsen OG. In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products. Basic Clin Pharmacol Toxicol 2008;102(5):466-475
68. Hennessy M, Kelleher D, Spiers JP, et al. St Johns wort increases expression of P-glycoprotein: implications for drug interactions. Br J Clin Pharmacol 2002;53(1):75-82 (Pubitemid 34117742)
69. Geick A, Eichelbaum M, Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem 2001;276(18):14581-14587 (Pubitemid 37373327)
70. Mitin T, Von Moltke LL, Court MH, Greenblatt DJ. Levothyroxine up-regulates P-glycoprotein independent of the pregnane X receptor. Drug Metab Dispos 2004;32(8):779-782 (Pubitemid 38955604)
71. Moore LB, Goodwin B, Jones SA, et al. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 2000;97(13):7500-7502
72. Han Y. Modulation of drug transport pathways by spices (PhD Thesis): National University of Singapore; 2007
73. Suresh D, Srinivasan K. Studies on the in vitro absorption of spice principles-curcumin, capsaicin and piperine in rat intestines. Food Chem Toxicol 2007;45(8):1437-1442 (Pubitemid 47031388)
74. Hirotani YYK, Tomishi H, Nishihori T, et al. Effects of capsaicin on the pharmacokinetics of digoxin, phenytoin, and theophylline in rats. Jpn J Ther Drug Monit 2007;24:23-28
75. Laroche M, Choudri S, Gallicano K, Foster B. Severe gastrointestinal toxicity with concomitant ingestion of ritonavir and garlic. Can J Infect Dis Supp 1998;9:471P
76. Gallicano K, Foster B, Choudhri S. Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers. Br J Clin Pharmacol 2003;55(2):199-202 (Pubitemid 36237866)
77. Piscitelli SC, Burstein AH, Welden N, et al. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 2002;34(2):234-238 (Pubitemid 34028358)
78. Arora A, Seth K, Shukla Y. Reversal of P-glycoprotein-mediated multidrug resistance by diallyl sulfide in K562 leukemic cells and in mouse liver. Carcinogenesis 2004;25(6):941-949 (Pubitemid 38886080)
79. Patel J, Buddha B, Dey S, et al. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity. Am J Ther 2004;11(4):262-277
80. Foster BC, Foster MS, Vandenhoek S, et al. An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. J Pharm Pharm Sci 2001;4(2):176-184 (Pubitemid 34305609)
81. Govindarajan VS. Ginger-chemistry, technology, and quality evaluation: part 1. Crit Rev Food Sci Nutr 1982;17(1):1-96
82. Perloff MD, von Moltke LL, Stormer E, et al. Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure. Br J Pharmacol 2001;134(8):1601-1608 (Pubitemid 34038092)
83. Wang Z, Hamman MA, Huang SM, et al. Effect of St John's wort on the pharmacokinetics of fexofenadine. Clin Pharmacol Ther 2002;71(6):414-420 (Pubitemid 34701348)
84. Madabushi R, Frank B, Drewelow B, et al. Hyperforin in St. John's wort drug interactions. Eur J Clin Pharmacol 2006;62(3):225-233 (Pubitemid 43357581)
85. Bauer S, Stormer E, Johne A, et al. Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients. Br J Clin Pharmacol 2003;55(2):203-211 (Pubitemid 36237867)
86. Barone GW, Gurley BJ, Ketel BL, et al. Drug interaction between St. John's wort and cyclosporine. Ann Pharmacother 2000;34(9):1013-1016
87. Ruschitzka F, Meier PJ, Turina M, et al. Acute heart transplant rejection due to Saint John's wort. Lancet 2000;355(9203):548-549 (Pubitemid 30088678)
88. Dresser GK, Schwarz UI, Wilkinson GR, Kim RB. Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects. Clin Pharmacol Ther 2003;73(1):41-50 (Pubitemid 36158485)
89. Piscitelli SC, Burstein AH, Chaitt D, et al. Indinavir concentrations and St John's wort. Lancet 2000;355(9203):547-548
90. Yue QY, Bergquist C, Gerden B. Safety of St John's wort (Hypericum perforatum). Lancet 2000;355(9203):576-577
91. Pfrunder A, Schiesser M, Gerber S, et al. Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial. Br J Clin Pharmacol 2003;56(6):683-690 (Pubitemid 37491722)
92. Hall SD, Wang Z, Huang SM, et al. The interaction between St John's wort and an oral contraceptive. Clin Pharmacol Ther 2003;74(6):525-535 (Pubitemid 37521996)
93. Tannergren C, Engman H, Knutson L, et al. St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism. Clin Pharmacol Ther 2004;75(4):298-309 (Pubitemid 38471555)
94. Sugimoto K, Ohmori M, Tsuruoka S, et al. Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin. Clin Pharmacol Ther 2001;70(6):518-524 (Pubitemid 34008408)
95. Schwarz UI, Buschel B, Kirch W. Unwanted pregnancy on self-medication with St John's wort despite hormonal contraception. Br J Clin Pharmacol 2003;55(1):112-113 (Pubitemid 36110847)
96. Molnar J, Szabo D, Pusztai R, et al. Membrane associated antitumor effects of crocine-, ginsenoside- and cannabinoid derivates. Anticancer Res 2000;20(2A):861-867 (Pubitemid 30240646)
97. Kitagawa S, Takahashi T, Nabekura T, et al. Inhibitory effects of ginsenosides and their hydrolyzed metabolites on daunorubicin transport in KB-C2 cells. Biol Pharm Bull 2007;30(10):1979-1981 (Pubitemid 47607790)
98. Kim SW, Kwon HY, Chi DW, et al. Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg(3). Biochem Pharmacol 2003;65(1):75-82
99. Choi CH, Kang G, Min YD. Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng. Planta Med 2003;69(3):235-240 (Pubitemid 36470128)
100. Jung CH, Seog HM, Choi IW, Cho HY. Antioxidant activities of cultivated and wild Korean ginseng leaves. Food Chem 2004;92:535-540
101. Kitagawa S, Nabekura T, Takahashi T, et al. Structure-activity relationships of the inhibitory effects of flavonoids on P-glycoprotein-mediated transport in KB-C2 cells. Biol Pharm Bull 2005;28(12):2274-2278 (Pubitemid 41757420)
102. Ofer M, Wolffram S, Koggel A, et al. Modulation of drug transport by selected flavonoids: involvement of P-gp and OCT? Eur J Pharm Sci 2005;25(2-3):263-271
103. Piao Y, Shin SC, Choi JS. Effects of oral kaempferol on the pharmacokinetics of tamoxifen and one of its metabolites, 4-hydroxytamoxifen, after oral administration of tamoxifen to rats. Biopharm Drug Dispos 2008;29(4):245-249 (Pubitemid 351802847)
104. Limtrakul P, Khantamat O, Pintha K. Inhibition of P-glycoprotein function and expression by kaempferol and quercetin. J Chemother 2005;17(1):86-95 (Pubitemid 40463763)
105. Kajiwara H, Hemmings AM, Hirano H. Evidence of metal binding activities of pentadecapeptide from Panax ginseng. J Chromatogr B Biomed Appl 1996;687(2):443-448 (Pubitemid 27046551)
106. Hasegawa H, Sung JH, Benno Y. Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins. Planta Med 1997;63(5):436-440 (Pubitemid 27399983)
107. Flora K, Hahn M, Rosen H, Benner K. Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol 1998;93(2):139-143 (Pubitemid 29063954)
108. Ding T, Tian S, Zhang Z, et al. Determination of active component in silymarin by RP-LC and LC/MS. J Pharm Biomed Anal 2001;26(1):155-161 (Pubitemid 32635293)
109. Maitrejean M, Comte G, Barron D, et al. The flavanolignan silybin and its hemisynthetic derivatives, a novel series of potential modulators of P-glycoprotein. Bioorg Med Chem Lett 2000;10(2):157-160 (Pubitemid 30055446)
110. Zhang S, Morris ME. Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport. J Pharmacol Exp Ther 2003;304(3):1258-1267 (Pubitemid 36254439)
111. Zhang S, Morris ME. Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells. Pharm Res 2003;20(8):1184-1191 (Pubitemid 36951843)
112. DiCenzo R, Shelton M, Jordan K, et al. Coadministration of milk thistle and indinavir in healthy subjects. Pharmacotherapy 2003;23(7):866-870 (Pubitemid 36875670)
113. Piscitelli SC, Formentini E, Burstein AH, et al. Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers. Pharmacotherapy 2002;22(5):551-556 (Pubitemid 34464940)
114. Gurley BJ, Barone GW, Williams DK, et al. Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplmentation on digoxin pharmacokinetics in humans. Drug Metab Dispos 2006;34(1):69-74 (Pubitemid 43045694)
115. Verhoeven DT, Goldbohm RA, van Poppel G, et al. Epidemiological studies on brassica vegetables and cancer risk. Cancer Epidemiol Biomarkers Prev 1996;5(9):733-748 (Pubitemid 26304649)
116. Fahey JWZA, Talalay P. The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochemistry 2001;56:5-51 (Pubitemid 32063165)
117. Aggarwal BB, Ichikawa H. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 2005;4(9):1201-1215 (Pubitemid 41365390)
118. Shukla Y, Kalra N, Katiyar S, et al. Chemopreventive effect of indole-3-carbinol on induction of preneoplastic altered hepatic foci. Nutr Cancer 2004;50(2):214-220
119. Moiseeva EP, Almeida GM, Jones GD, Manson MM. Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells. Mol Cancer Ther 2007;6(11):3071-3079 (Pubitemid 350206785)
120. Kassie F, Anderson LB, Scherber R, et al. Indole-3-carbinol inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone plus benzo(a)pyrene-induced lung tumorigenesis in A/J mice and modulates carcinogen-induced alterations in protein levels. Cancer Res 2007;67(13):6502-6511 (Pubitemid 47037536)
121. Souli E, Machluf M, Morgenstern A, et al. Indole-3-carbinol (I3C) exhibits inhibitory and preventive effects on prostate tumors in mice. Food Chem Toxicol 2008;46(3):863-870 (Pubitemid 351172558)
122. Cope RB, Loehr C, Dashwood R, Kerkvliet NI. Ultraviolet radiation-induced non-melanoma skin cancer in the Crl:SKH1:hr-BR hairless mouse: augmentation of tumor multiplicity by chlorophyllin and protection by indole-3-carbinol. Photochem Photobiol Sci 2006;5(5):499-507 (Pubitemid 43725972)
123. Jin L, Qi M, Chen DZ, et al. Indole-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV16) transgenic mice. Cancer Res 1999;59(16):3991-3997 (Pubitemid 29393567)
124. Raj MH, Abd Elmageed ZY, Zhou J, et al. Synergistic action of dietary phyto-antioxidants on survival and proliferation of ovarian cancer cells. Gynecol Oncol 2008;110(3):432-438
125. Tanaka T, Kojima T, Morishita Y, Mori H. Inhibitory effects of the natural products indole-3-carbinol and sinigrin during initiation and promotion phases of 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Jpn J Cancer Res 1992;83(8):835-842
126. Fahey JW, Talalay P. Antioxidant functions of sulforaphane: a potent inducer of Phase II detoxication enzymes. Food Chem Toxicol 1999;37(9-10):973- 979 (Pubitemid 29481800)
127. Singh SV, Srivastava SK, Choi S, et al. Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. J Biol Chem 2005;280(20):19911-19924 (Pubitemid 41379520)
128. Frydoonfar HR, McGrath DR, Spigelman AD. Sulforaphane inhibits growth of a colon cancer cell line. Colorectal Dis 2004;6(1):28-31 (Pubitemid 38195489)
129. Christensen JG, LeBlanc GA. Reversal of multidrug resistance in vivo by dietary administration of the phytochemical indole-3-carbinol. Cancer Res 1996;56(3):574-581 (Pubitemid 26043656)
130. Arora A, Seth K, Kalra N, Shukla Y. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol. Toxicol Appl Pharmacol 2005;202(3):237-243 (Pubitemid 40164277)
131. Arora A, Shukla Y. Modulation of vinca-alkaloid induced P-glycoprotein expression by indole-3-carbinol. Cancer Lett 2003;189(2):167-173 (Pubitemid 35461993)
132. Yan YE, Wang H, Wang T, Zeng HG. Indole-3-carbinol alters placental cytochrome P450 1A1 and P-glycoprotein levels in rats: a potential role in intensifying fetal intrauterine growth-retardation produced by tobacco smoke. Exp Toxicol Pathol 2006;58(1):39-47 (Pubitemid 44093216)
133. Tseng E, Kamath A, Morris ME. Effect of organic isothiocyanates on the P-glycoprotein- and MRP1-mediated transport of daunomycin and vinblastine. Pharm Res 2002;19(10):1509-1515 (Pubitemid 35266556)
134. Hu K, Morris ME. Effects of benzyl-, phenethyl-, and alpha-naphthyl isothiocyanates on P-glycoprotein- and MRP1-mediated transport. J Pharm Sci 2004;93(7):1901-1911 (Pubitemid 38823715)
135. Ji Y, Morris ME. Transport of dietary phenethyl isothiocyanate is mediated by multidrug resistance protein 2 but not P-glycoprotein. Biochem Pharmacol 2005;70(4):640-647 (Pubitemid 40978554)
136. Harris KE, Jeffery EH. Sulforaphane and erucin increase MRP1 and MRP2 in human carcinoma cell lines. J Nutr Biochem 2008;19(4):246-254 (Pubitemid 351313891)
137. Nabekura T, Kamiyama S, Kitagawa S. Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. Biochem Biophys Res Commun 2005;327(3):866-870 (Pubitemid 40092828)
138. Gee JM, DuPont MS, Rhodes MJ, Johnson IT. Quercetin glucosides interact with the intestinal glucose transport pathway. Free Radic Biol Med 1998;25(1):19-25 (Pubitemid 28285266)
139. Shapiro AB, Ling V. Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein. Biochem Pharmacol 1997;53(4):587-596 (Pubitemid 27149553)
140. Yang CY, Chao PD, Hou YC, et al. Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats. Food Chem Toxicol 2006;44(9):1572-1578 (Pubitemid 43994271)
141. Arai Y, Watanabe S, Kimira M, et al. Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J Nutr 2000;130(9):2243-2250 (Pubitemid 30682743)
142. Chung SY, Sung MK, Kim NH, et al. Inhibition of P-glycoprotein by natural products in human breast cancer cells. Arch Pharm Res 2005;28(7):823-828 (Pubitemid 43080161)
143. Konishi T, Satsu H, Hatsugai Y, et al. A bitter melon extract inhibits the P-glycoprotein activity in intestinal Caco-2 cells: monoglyceride as an active compound. Biofactors 2004;22(1-4):71-74
144. Konishi T, Satsu H, Hatsugai Y, et al. Inhibitory effect of a bitter melon extract on the P-glycoprotein activity in intestinal Caco-2 cells. Br J Pharmacol 2004;143(3):379-387 (Pubitemid 39424826)
145. Motohashi N, Kurihara T, Wakabayashi H, et al. Biological activity of a fruit vegetable, "Anastasia green", a species of sweet pepper. In Vivo 2001;15(5):437-442
146. Takehiko Y, Raj JL, sDjong-Chi C, Mujo K. Chemistry and applications of green tea. New York: CRC Press; 1997
147. Lee MJ, Wang ZY, Li H, et al. Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomarkers Prev 1995;4(4):393-399
148. Song JM, Lee KH, Seong BL. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res 2005;68(2):66-74 (Pubitemid 41565520)
149. Thangapazham RL, Passi N, Maheshwari RK. Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells. Cancer Biol Ther 2007;6(12):1938-1943 (Pubitemid 351590407)
150. Weinreb O, Amit T, Youdim MB. A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate. Free Radic Biol Med 2007;43(4):546-556 (Pubitemid 47058234)
151. Engdal S, Nilsen OG. Inhibition of P-glycoprotein in Caco-2 cells: effects of herbal remedies frequently used by cancer patients. Xenobiotica 2008;38(6):559-573 (Pubitemid 351882975)
152. Ballinger JR, Bannerman J, Boxen I, et al. Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells. J Nucl Med 1996;37(9):1578-1582 (Pubitemid 26321652)
153. Zhu A, Wang X, Guo Z. Study of tea polyphenol as a reversal agent for carcinoma cell lines' multidrug resistance (study of TP as a MDR reversal agent). Nucl Med Biol 2001;28(6):735-740 (Pubitemid 32772878)
154. Jodoin J, Demeule M, Beliveau R. Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochim Biophys Acta 2002;1542(1-3):149-159
155. Kitagawa S, Nabekura T, Kamiyama S. Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells. J Pharm Pharmacol 2004;56(8):1001-1005 (Pubitemid 39140055)
156. Zamora JM, Pearce HL, Beck WT. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol Pharmacol 1988;33(4):454-462 (Pubitemid 18111607)
157. Mei Y, Qian F, Wei D, Liu J. Reversal of cancer multidrug resistance by green tea polyphenols. J Pharm Pharmacol 2004;56(10):1307-1314 (Pubitemid 39369002)
158. Sadzuka Y, Sugiyama T, Sonobe T. Efficacies of tea components on doxorubicin induced antitumor activity and reversal of multidrug resistance. Toxicol Lett 2000;114(1-3):155-162 (Pubitemid 30125452)
159. Bohme M, Buchler M, Muller M, Keppler D. Differential inhibition by cyclosporins of primary-active ATP-dependent transporters in the hepatocyte canalicular membrane. FEBS Lett 1993;333(1-2):193-196 (Pubitemid 23306967)
160. Vaidyanathan JB, Walle T. Cellular uptake and efflux of the tea flavonoid (-)epicatechin-3-gallate in the human intestinal cell line Caco-2. J Pharmacol Exp Ther 2003;307(2):745-752 (Pubitemid 37310692)
161. Vaidyanathan JB, Walle T. Transport and metabolism of the tea flavonoid (-)-epicatechin by the human intestinal cell line Caco-2. Pharm Res 2001;18(10):1420-1425 (Pubitemid 32977247)
162. Wang EJ, Barecki-Roach M, Johnson WW. Elevation of P-glycoprotein function by a catechin in green tea. Biochem Biophys Res Commun 2002;297(2):412-418 (Pubitemid 35216187)
163. Netsch MI, Gutmann H, Luescher S, et al. Inhibitory activity of a green tea extract and some of its constituents on multidrug resistance-associated protein 2 functionality. Planta Med 2005;71(2):135-141 (Pubitemid 40363556)